Positrigo
2 known investors
Positrigo develops NeuroLF, an ultra-compact brain Positron Emission Tomography (PET) device for functional brain imaging at a lower cost than conventional systems. The technology targets the diagnosis of brain-related disorders, starting with dementia and Alzheimer's disease.